Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 5/20 | 0.77 |
| ▸ | ITGB1 | P05556 | 8/20 | 0.58 |
| ▸ | ITGA5 | P08648 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | ITGAV | P06756 | 2/20 | 0.52 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.50 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.50 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5690347 | 0.94 | ITGA4 (0.75) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL3860100 | 0.88 | ITGA4 (0.67) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL7163529 | 0.88 | ITGA4 (0.67) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL6714530 | 0.87 | ITGA4 (0.66) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL7069740 | 0.87 | ALDH1A1 (0.70) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL7066469 | 0.87 | ALDH1A1 (0.70) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL27514023 | 0.87 | ALDH1A1 (0.70) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL6710892 | 0.87 | ALDH1A1 (0.70) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL6439213 | 0.87 | ALDH1A1 (0.70) | ITGA4ITGB1ITGA5ALDH1A1ITGAV | |
| SCHEMBL5690845 | 0.86 | ITGB1 (0.63) | ITGA4ITGB1ITGA5ALDH1A1ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1942161-B | Compositions and treatments for demyelinating diseases and paralysis by administration of remyelinating drugs | ELAN PHARM INC | 2012-05-30 | — | — | CN | disclosed |
| EP-1635822-A4 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | ELAN PHARM INC (US) | 2009-06-24 | — | — | EP | disclosed |
| EP-1592386-A4 | COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS | ELAN PHARM INC (US) | 2007-06-13 | — | — | EP | disclosed |
| CN-1942161-A | Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents | ELAN PHARM INC (US) | 2007-04-04 | — | — | CN | disclosed |
| EP-1635822-A2 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | Elan Pharmaceuticals, Inc. (US) | 2006-03-22 | — | — | EP | disclosed |
| EP-1592386-A2 | COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS | Elan Pharmaceuticals, Inc. (US) | 2005-11-09 | — | — | EP | disclosed |
| WO-2005000246-A2 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | ELAN PHARMACEUTICALS, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004066931-A2 | COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS | ELAN PHARMACEUTICALS INC. (US) | 2004-08-12 | — | — | WO | disclosed |